Today: 9 April 2026
Constellation Software resets CSU.DB debenture rate to 8.6% as Canada’s inflation cools
21 January 2026
1 min read

Constellation Software resets CSU.DB debenture rate to 8.6% as Canada’s inflation cools

Toronto, Jan 21, 2026, 10:46 (EST)

  • On March 31, Constellation will lower the interest rate on its Series 1 debentures to 8.6% from the previous 8.9%
  • The coupon is determined by the annual-average Canada CPI with an added fixed 6.5 percentage points
  • Statistics Canada reported that Canada’s annual-average CPI climbed 2.1% in 2025

Constellation Software Inc announced it will lower the annual interest rate on its unsecured subordinated floating rate debentures, Series 1, to 8.6% starting March 31, down from the current 8.9%. The adjustment reflects the annual average change in Canada’s all-items Consumer Price Index for the 12 months ending Dec. 31, 2025, plus a fixed spread of 6.5 percentage points. GlobeNewswire

The Toronto market was active at the time of publication, shining a spotlight on a lesser-known slice of Constellation’s capital structure. Investors hold notes whose coupons rise with inflation, untouched by changes to the central bank’s overnight rate.

The slowdown matches a cooler annual inflation trend. Statistics Canada reported that Canada’s CPI increased 2.1% on an annual average in 2025, down from a 2.4% rise in 2024. Statistics Canada

Constellation confirmed the new 8.6% rate will apply starting with the June 30, 2026 interest payment. The existing 8.9% rate remains effective until March 30.

Inflation remains uneven on the monthly tape. Statistics Canada reported consumer prices climbed 2.4% year-on-year in December, up from 2.2% in November. However, the CPI dropped 0.2% month-over-month, with the agency citing base effects tied to a temporary GST/HST break the previous year. Statistics Canada

Economists told Reuters that the drop in core inflation measures should allow the Bank of Canada to hold rates steady. Andrew Grantham, senior economist at CIBC Capital Markets, noted the data remain “still consistent with underlying inflation being close to 2%.” Fitch Ratings director Jessica Hinds said the report is “highly unlikely to change the calculus” for the central bank. Reuters

A debenture is essentially a corporate IOU. When it’s called “unsecured,” that means there’s no specific collateral backing the debt. “Subordinated” indicates it sits below senior debt in line if the company goes under.

Constellation calls itself an acquirer and operator of vertical market software firms — specialized software designed for particular industries and essential daily tasks. CSi Software

Yet the CPI connection works both ways. Should inflation ease more, the coupon will drop again at the next reset, tightening income for investors; if inflation picks up, Constellation’s interest expenses climb just as quickly.

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:10 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Applied Materials stock rises as AMAT steadies with markets; Needham lifts target to $390
Previous Story

Applied Materials stock rises as AMAT steadies with markets; Needham lifts target to $390

Thermo Fisher stock price rises nearly 2% as Australia starts Clario deal review; earnings next in focus
Next Story

Thermo Fisher stock price rises nearly 2% as Australia starts Clario deal review; earnings next in focus

Go toTop